DO LONG-TERM ADMINISTRATION OF TAMOXIFEN AFFECT BONE-MINERAL DENSITY

被引:20
作者
NEAL, AJ
EVANS, K
HOSKIN, PJ
机构
[1] ROYAL LONDON HOSP TRUST,LONDON E1 1BB,ENGLAND
[2] MT VERNON HOSP,NORTHWOOD,MIDDX,ENGLAND
关键词
D O I
10.1016/0959-8049(93)90454-N
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A retrospective study was performed to determine whether the long-term (5 years or more) administration of tamoxifen is detrimental to bone mineral density (BMD). 19 patients taking adjuvant tamoxifen for breast cancer were paired with 19 controls comparable in age, time since menopause and performance status. BMD was measured at the femoral neck, lumbar spine and total body by dual energy X-ray absorptiometry (DEXA). There was no detrimental effect on BMD at any site. There was a trend towards an increase in BMD at the femoral neck. There were minor decreases in the serum calcium, phosphate and alkaline phosphatase.
引用
收藏
页码:1971 / 1973
页数:3
相关论文
共 21 条
[1]   OSTEOPOROSIS AFTER OOPHORECTOMY FOR NON-MALIGNANT DISEASE IN PREMENOPAUSAL WOMEN [J].
AITKEN, JM ;
HART, DM ;
ANDERSON, JB ;
LINDSAY, R ;
SMITH, DA ;
SPEIRS, CF .
BRITISH MEDICAL JOURNAL, 1973, 2 (5862) :325-328
[2]  
CITRIN DL, 1985, P INT BREAST CANCER
[3]  
CUZICK J, 1992, EUR J CANCER, V29, P15
[4]  
DAWES P, 1990, BRIT J CANCER, V62, P34
[5]  
EBCTC Group, 1992, LANCET, V339, P1
[6]   EVIDENCE OF ESTROGEN-RECEPTORS IN NORMAL HUMAN OSTEOBLAST-LIKE CELLS [J].
ERIKSEN, EF ;
COLVARD, DS ;
BERG, NJ ;
GRAHAM, ML ;
MANN, KG ;
SPELSBERG, TC ;
RIGGS, BL .
SCIENCE, 1988, 241 (4861) :84-86
[7]   BONE-MINERAL CONTENT OF WOMEN RECEIVING TAMOXIFEN FOR MASTALGIA [J].
FENTIMAN, IS ;
CALEFFI, M ;
RODIN, A ;
MURBY, B ;
FOGELMAN, I .
BRITISH JOURNAL OF CANCER, 1989, 60 (02) :262-264
[8]  
FENTIMAN IS, 1986, LANCET, V1, P287
[9]   LONG-TERM ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER - EFFECT ON BONE-MINERAL DENSITY IN POSTMENOPAUSAL WOMEN [J].
FORNANDER, T ;
RUTQVIST, LE ;
SJOBERG, HE ;
BLOMQVIST, L ;
MATTSSON, A ;
GLAS, U .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) :1019-1024
[10]  
GOTFREDSEN A, 1984, CANCER, V53, P853, DOI 10.1002/1097-0142(19840215)53:4<853::AID-CNCR2820530406>3.0.CO